13F filer · CIK 1422848 ↗

Capital Research Global Investors

You are looking at Q4 2018. See the latest, Q2 2026 →

Reported value

$287.02B

−17% on the quarter before

Positions

417

23 new · 42 sold out

Top 10

28.8%

of the value

Est. gain

−$45.29B

on stocks held all quarter

Est. return

−14.5%

on those stocks since Q3 2018

Filed

Feb 14, 2019

On SEC EDGAR ↗

Positions as of Dec 31, 2018, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 48% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.

Abbvie Inc5.6%
Microsoft3.9%Meta3.2%
Abbott Laboratories3.1%
Amazon2.5%Netflix2.4%
Amgen Inc2.4%
Broadcom2.2%Alphabet1.8%
Verizon Communications Inc1.8%
Alphabet1.8%
Unitedhealth Group Inc1.7%
Intel1.6%
Gilead Sciences Inc1.6%
Eog Resources Inc1.4%
Exxon Mobil Corp1.3%
Philip Morris International1.3%
Thermo Fisher Scientific Inc1.2%
General Dynamics Corp1.2%
Nike Inc Cl B1.2%
Coca-Cola Co1.2%
Mastercard1.2%
Altria Group Inc1.1%
Lowes Companies Inc1.1%

Largest buys

Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Linde Plc~$1.99BNew · 0.0% → 0.7%+12,771,339 shares
  2. Cigna Corp~$1.61BNew · 0.0% → 0.6%+8,459,944 shares
  3. Meta~$1.24BAdded · 2.9% → 3.2%+9,458,143 shares
  4. Jpmorgan Chase And Co~$951.5MAdded · 0.5% → 0.9%+9,747,235 shares
  5. Worldpay Inc Cl A~$806.2MAdded · 0.4% → 0.7%+10,531,162 shares
  6. Simon Property Group Inc (Reit)~$717.2MAdded · 0.1% → 0.4%+4,269,006 shares
  7. Philip Morris International~$569.4MAdded · 1.1% → 1.3%+8,529,564 shares
  8. Coca-Cola Co~$480.0MAdded · 0.8% → 1.2%+10,137,402 shares
  9. Berkshire Hathaway Inc Cl B~$447.0MAdded · 0.5% → 0.7%+2,189,177 shares
  10. United Parcel Service Inc Cl B~$409.6MNew · 0.0% → 0.1%+4,199,406 shares

Largest sells

Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Netflix~$2.01BCut · 3.6% → 2.4%−7,490,880 shares
  2. Amazon~$2.00BCut · 3.5% → 2.5%−1,333,383 shares
  3. Alphabet~$1.38BCut · 2.2% → 1.8%−1,336,509 shares
  4. Express Scripts Holding Co~$1.10BSold out · 0.3% → 0.0%−11,580,091 shares
  5. Cigna Corp~$682.2MSold out · 0.2% → 0.0%−3,275,920 shares
  6. Boeing Co~$551.6MCut · 0.4% → 0.3%−1,710,493 shares
  7. Nike Inc Cl B~$536.9MCut · 1.3% → 1.2%−7,242,197 shares
  8. Illumina Inc~$535.3MCut · 0.8% → 0.6%−1,784,868 shares
  9. Alphabet~$512.9MCut · 1.9% → 1.8%−490,838 shares
  10. Wells Fargo And Co~$500.1MCut · 0.5% → 0.3%−10,852,735 shares

Holdings

As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Abbvie IncCOMMON STOCK · shares −1.5% · price −2.5%5.6%$16.00B−$414.8M
MicrosoftCOMMON STOCK · shares +0.8% · price −11.2%3.9%$11.16B−$1.39B
MetaCOMMON STOCK · shares +16% · price −20.3%3.2%$9.15B−$2.01B
Abbott LaboratoriesCOMMON STOCK · shares −2.6% · price −1.4%3.1%$8.82B−$125.6M
AmazonCOMMON STOCK · shares −22% · price −25.0%2.5%$7.07B−$2.36B
NetflixCOMMON STOCK · shares −23% · price −28.5%2.4%$6.88B−$2.74B
Amgen IncCOMMON STOCK · shares +2.1% · price −6.1%2.4%$6.84B−$434.4M
BroadcomCOMMON STOCK · shares −1.6% · price +3.1%2.2%$6.43B+$190.8M
AlphabetCOMMON STOCK · shares −21% · price −13.2%1.8%$5.27B−$804.0M
Verizon Communications IncCOMMON STOCK · shares −7.2% · price +5.3%1.8%$5.19B+$261.3M
AlphabetCOMMON STOCK · shares −9.3% · price −13.4%1.8%$5.03B−$779.6M
Unitedhealth Group IncCOMMON STOCK · shares +1.0% · price −6.4%1.7%$4.79B−$322.4M
IntelCOMMON STOCK · shares −9.5% · price −0.8%1.6%$4.58B−$35.1M
Gilead Sciences IncCOMMON STOCK · shares +3.9% · price −19.0%1.6%$4.54B−$1.02B
Eog Resources IncCOMMON STOCK · shares +4.7% · price −31.6%1.4%$3.99B−$1.76B
Exxon Mobil CorpCOMMON STOCK · shares +11% · price −19.8%1.3%$3.78B−$837.5M
Philip Morris InternationalCOMMON STOCK · shares +18% · price −18.1%1.3%$3.67B−$685.5M
Thermo Fisher Scientific IncCOMMON STOCK · shares +0.2% · price −8.3%1.2%$3.57B−$322.4M
General Dynamics CorpCOMMON STOCK · shares +8.4% · price −23.2%1.2%$3.53B−$983.9M
Nike Inc Cl BCOMMON STOCK · shares −13% · price −12.5%1.2%$3.49B−$498.4M
Coca-Cola CoCOMMON STOCK · shares +17% · price +2.5%1.2%$3.35B+$70.3M
MastercardCOMMON STOCK · shares −8.9% · price −15.3%1.2%$3.34B−$601.5M
Altria Group IncCOMMON STOCK · shares −8.8% · price −18.1%1.1%$3.24B−$716.1M
Lowes Companies IncCOMMON STOCK · shares +6.1% · price −19.6%1.1%$3.10B−$711.8M
AlibabaCOMMON STOCK · shares −8.9% · price −16.8%0.93%$2.67B−$540.2M
Total · 417 positions100%$287.02B−$45.29B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2018 to Q4 2018: 385 stocks held throughout, down $45.29B (−14.5%).

  1. Verizon Communications Inc+$261.3M+5%
  2. Cme Group Inc Cl A+$195.3M+11%
  3. Broadcom+$190.8M+3%
  4. Mcdonalds Corp+$117.2M+6%
  5. Hdfc Bank Ltd ADR+$80.9M+10%
  6. Microsoft−$1.39B−11%
  7. Eog Resources Inc−$1.76B−32%
  8. Meta−$2.01B−20%
  9. Amazon−$2.36B−25%
  10. Netflix−$2.74B−28%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$800.00B$400.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$716.87B+11%SEC ↗
Q1 2026$644.56B+19%SEC ↗
Q4 2025$541.73B+2%SEC ↗
Q3 2025$532.97B+7%SEC ↗
Q2 2025$499.46B+9%SEC ↗
Q1 2025$459.90B−5%SEC ↗
Q4 2024$486.38B+1%SEC ↗
Q3 2024$481.14B+6%SEC ↗
Q2 2024$455.74B+3%SEC ↗
Q1 2024$441.98B+9%SEC ↗
Q4 2023$406.47B+12%SEC ↗
Q3 2023$363.16B−3%SEC ↗
Q2 2023$373.18B+7%SEC ↗
Q1 2023$350.40B+6%SEC ↗
Q4 2022$330.88B+9%SEC ↗
Q3 2022$304.37B−5%SEC ↗
Q2 2022$321.05B−21%SEC ↗
Q1 2022$405.10B−11%SEC ↗
Q4 2021$452.67B+6%SEC ↗
Q3 2021$428.65B−0%SEC ↗
Q2 2021$429.52B+5%SEC ↗
Q1 2021$408.71B+6%SEC ↗
Q4 2020$385.30B+16%SEC ↗
Q3 2020$333.11B+5%SEC ↗
Q2 2020$316.13B+24%SEC ↗
Q1 2020$254.90B−24%SEC ↗
Q4 2019$333.48B+9%SEC ↗
Q3 2019$304.85B−3%SEC ↗
Q2 2019$314.99B−0%SEC ↗
Q1 2019$315.45B+10%SEC ↗
Q4 2018$287.02B−17%SEC ↗
Q3 2018$344.02B−6%SEC ↗
Q2 2018$366.12B+4%SEC ↗
Q1 2018$351.43B+3%SEC ↗
Q4 2017$340.76B+3%SEC ↗
Q3 2017$331.24B+4%SEC ↗
Q2 2017$319.49B+1%SEC ↗
Q1 2017$317.04B+3%SEC ↗
Q4 2016$308.47B+2%SEC ↗
Q3 2016$302.53B+3%SEC ↗
Q2 2016$292.47B+1%SEC ↗
Q1 2016$290.06BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.